The Mammotome biopsy system is an effective treatment strategy for breast abscess.

Abstract

BACKGROUND:

Although most breast abscesses can be treated with the current first-line treatment of antibiotics by needle aspiration, the therapeutic duration is lengthy and recurrences often occur. Therefore, we aimed to investigate the clinical efficacy of the Mammotome biopsy system (Johnson & Johnson Corp., New Brunswick, NJ) in a cohort of patients with breast abscesses.

METHODS:

Forty lactating and 30 nonlactating breast abscess patients with unfavorable outcomes with antibiotic treatment and/or needle aspiration failure were recruited and treated with the Mammotome biopsy system.

RESULTS:

Skin inflammation of all patients disappeared within 6 days with no recurrence. The clinical outcomes in patients with an abscess size ≤ 3.5 cm was significantly better than those with an abscess size >3.5 cm (P = .025).

CONCLUSIONS:

The Mammotome biopsy system, an effective treatment strategy that is minimally invasive and less damaging, in combination with appropriate antibiotic therapy can be used safely as the first-line approach to breast abscess management.

• Authors: Keren Wang, Yuqin Ye, Guang Sun, Zheli Xu
• Journal: American journal of surgery (Am J Surg) Vol. 205 Issue 1 Pg. 35-8 (Jan 2013) ISSN: 1879-1883 [Electronic] United States
• PMID: 23036601 (Publication Type: Evaluation Study, Journal Article)
• Copyright: Copyright © 2013 Elsevier Inc. All rights reserved.

Chemical References

• Anti-Bacterial Agents

Topics

• Abscess (microbiology, pathology, therapy)
• Adult
• Anti-Bacterial Agents (therapeutic use)
• Biopsy, Needle (instrumentation)
• Breast Diseases (microbiology, pathology, therapy)
• Cohort Studies
• Female
• Humans
• Lactation
• Middle Aged
• Ultrasonography, Interventional
• Vacuum
• Young Adult